---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-120276"
form_type: "8-K"
ticker: "INCY"
cik: "0000879169"
company_name: "INCYTE CORP"
filed_at: "2021-09-28T23:59:59+00:00"
generated_at: "2026-06-29T01:09:37.479484+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Incyte elects Otis W. Brawley, M.D. to board effective Sept 27, 2021

## Summary
- Board size increased to nine; Dr. Brawley elected as director effective September 27, 2021.
- Dr. Brawley is Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University.
- Previously Chief Medical and Scientific Officer of American Cancer Society (2007–2018).
- Will receive standard non-employee director compensation as described in 2021 proxy statement.
- Dr. Brawley also serves on boards of Lyell Immunopharma and PDS Biotechnology.

## SEC filing metadata
- accession: 0001104659-21-120276
- form_type: 8-K
- ticker: INCY
- cik: 0000879169
- company_name: INCYTE CORP
- filed_at: 2021-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879169/000110465921120276/0001104659-21-120276-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879169/000110465921120276/tm2128728d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-120276
- JSON: https://secwatch.observer/filing/0001104659-21-120276.json
- Plain text: https://secwatch.observer/filing/0001104659-21-120276.txt

## Key facts
- Executive change
  Otis W. Brawley, M.D. was elected as member of the Board of Directors at INCYTE CORP.
  - Action: elected
  - Role: member of the Board of Directors
  source text: Effective September 27, 2021, the Board of Directors of Incyte Corporation (the “Company”) increased the number of authorized members of the Board of Directors of the Company to nine and elected Otis W. Brawley, M.D., a member of the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/879169/000110465921120276/0001104659-21-120276-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.